These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 34297710)

  • 21. Is newly diagnosed diabetes a stronger risk factor than pre-existing diabetes for COVID-19 severity?
    Sathish T; de Mello GT; Cao Y
    J Diabetes; 2021 Feb; 13(2):177-178. PubMed ID: 33107708
    [No Abstract]   [Full Text] [Related]  

  • 22. Some Lessons Learned About Diabetes and COVID-19 During the Early Stage of the Epidemic in Norway.
    Birkeland KI
    J Diabetes Sci Technol; 2020 Jul; 14(4):718-719. PubMed ID: 32456527
    [No Abstract]   [Full Text] [Related]  

  • 23. COVID-19 and diabetes: Covidiabetology.
    Kalra S; Mittal S
    J Pak Med Assoc; 2020 Jun; 70(6):954-955. PubMed ID: 32810084
    [No Abstract]   [Full Text] [Related]  

  • 24. Service restriction during the COVID-19 pandemic and its impact on HbA
    Batten L; Chandrajay D; Burkinshaw C; Gill J; Jayagopal V
    Diabet Med; 2021 Jan; 38(1):e14414. PubMed ID: 33030220
    [No Abstract]   [Full Text] [Related]  

  • 25. Inflammation and hypercoagulopathy are predominant risk factors of severity in COVID-19 patients with diabetes mellitus: Summary of a meta-analysis.
    Dhar SK; Sachdeva K; Das M
    Diabetes Metab Syndr; 2021; 15(2):639-641. PubMed ID: 33676871
    [No Abstract]   [Full Text] [Related]  

  • 26. Time for a Change: Personal Experiences With COVID-19 and Diabetes.
    Best F
    J Diabetes Sci Technol; 2020 Jul; 14(4):716-717. PubMed ID: 32443943
    [No Abstract]   [Full Text] [Related]  

  • 27. COVID-19 and diabetes: What have we learned so far?
    Taher N; Huda MS; Chowdhury TA
    Clin Med (Lond); 2020 Jul; 20(4):e87-e90. PubMed ID: 32628128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico.
    Bello-Chavolla OY; Bahena-López JP; Antonio-Villa NE; Vargas-Vázquez A; González-Díaz A; Márquez-Salinas A; Fermín-Martínez CA; Naveja JJ; Aguilar-Salinas CA
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32474598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID-19: Considerations of Diabetes and Cardiovascular Disease Management.
    Ceriello A; Schnell O
    J Diabetes Sci Technol; 2020 Jul; 14(4):723-724. PubMed ID: 32475168
    [No Abstract]   [Full Text] [Related]  

  • 30. Commentary: COVID-19 in patients with diabetes.
    Hill MA; Mantzoros C; Sowers JR
    Metabolism; 2020 Jun; 107():154217. PubMed ID: 32220611
    [No Abstract]   [Full Text] [Related]  

  • 31. [Diabetes and hypertension as factors associated with Covid-19 lethality in Sonora, Mexico, 2020].
    Álvarez-López DI; Espinoza-Molina MP; Cruz-Loustaunau ID; Álvarez-Hernández G
    Salud Publica Mex; 2020; 62(5):456-457. PubMed ID: 33027852
    [No Abstract]   [Full Text] [Related]  

  • 32. Tuberculosis and Type 2 Diabetes Mellitus: An Inflammatory Danger Signal in the Time of Coronavirus Disease 2019.
    Wilkinson RJ
    Clin Infect Dis; 2021 Jan; 72(1):79-81. PubMed ID: 32533824
    [No Abstract]   [Full Text] [Related]  

  • 33. What Diabetes Can Teach us About Dealing With COVID-19 and Could it Be a Catalyst for Change in Diabetes?
    Stuhr A; Furber S
    J Diabetes Sci Technol; 2020 Jul; 14(4):791-792. PubMed ID: 32517567
    [No Abstract]   [Full Text] [Related]  

  • 34. Summary of recommendations regarding COVID-19 in children with diabetes: Keep Calm and Mind your Diabetes Care and Public Health Advice.
    International Society of Pediatric and Adolescent Diabetes (ISPAD)
    Pediatr Diabetes; 2020 May; 21(3):413-414. PubMed ID: 32346988
    [No Abstract]   [Full Text] [Related]  

  • 35. The COVID-19 Pandemic Revealed the Importance and Shortcomings of Technologies for Diabetes Support.
    Årsand E
    J Diabetes Sci Technol; 2020 Jul; 14(4):712-713. PubMed ID: 32460550
    [No Abstract]   [Full Text] [Related]  

  • 36. Inpatient Diabetes and Hyperglycemia Management Protocol in the COVID-19 Era.
    Aljehani FA; Funke K; Hermayer KL
    Am J Med Sci; 2020 Oct; 360(4):423-426. PubMed ID: 32736827
    [No Abstract]   [Full Text] [Related]  

  • 37. How diabetes management is adapting amid the COVID-19 pandemic.
    Ranscombe P
    Lancet Diabetes Endocrinol; 2020 Jul; 8(7):571. PubMed ID: 32422126
    [No Abstract]   [Full Text] [Related]  

  • 38. How COVID-19 Rapidly Transformed Clinical Practice at the Harold Schnitzer Diabetes Health Center Now and for the Future.
    Castle JR; Rocha L; Ahmann A
    J Diabetes Sci Technol; 2020 Jul; 14(4):721-722. PubMed ID: 32443962
    [No Abstract]   [Full Text] [Related]  

  • 39. The COVID-19 Pandemic: A "Tech"-tonic Shift Toward Virtual Diabetes Care.
    Ahn DT
    J Diabetes Sci Technol; 2020 Jul; 14(4):708-709. PubMed ID: 32450726
    [No Abstract]   [Full Text] [Related]  

  • 40. New-onset diabetes in "long COVID".
    Sathish T; Anton MC; Sivakumar T
    J Diabetes; 2021 Aug; 13(8):693-694. PubMed ID: 33893710
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.